Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:HUGE - Post Discussion

FSD Pharma Inc > FSD Pharma CEO Update Covar Pharma
View:
Post by DavidRosenberg on Oct 26, 2021 11:43pm

FSD Pharma CEO Update Covar Pharma

Comment by DavidRosenberg on Oct 26, 2021 11:44pm
https://youtu.be/xdpbXzmllHM
Comment by Mil_Man54 on Oct 26, 2021 11:51pm
Oh look.....another Proactive paid PR video where AD provides the questions to the interviewer.......not what should be considered as reliable information for anyone doing their DD....but you can't always count on Rosenberg to post this daily for the next week.....you know "just i case you missed it".
Comment by DavidRosenberg on Oct 26, 2021 11:54pm
  Looks like they will start another phase 2 trial for PEA they zoning in on two indications , that means for a particular illness to see if PEA helps , and the covar Pharma will make the drugs needed to do the clinical trials since they need them to produce the drug for the clinical trial for lucid stuff 
Comment by Mil_Man54 on Oct 27, 2021 12:04am
Another phase 2 trial.....I'm getting that feeling of deja vu and not in a good way......and AD has no idea what he's talking about and stubbled over his own words....maybe they should get an actual scientist to discuss what the plan is.....it is a mistake to have AD as the face of this regardless if he is the CEO....
Comment by DavidRosenberg on Oct 27, 2021 12:12am
  Anthony is Intreim CEO , his job right now is to make sure everything is solid and find a worthy CEO to take this forward who has experience in capital markets , who has succeeded in past endeavours etc
Comment by Mil_Man54 on Oct 27, 2021 12:15am
So maybe AD should focus on finding a suitable CEO and leaving the paid PR interviews to the people who actually know what they're talking about....he;s embarassing and a poor representative for FSD.....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities